Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
In the context of Chlorpropamide & Type 2 diabetes (T2D), chlorpropamide is FDA‑approved as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes. It was first approved in the 1950s and is classified as a first‑generation sulfonylurea, stimulating insulin secretion from pancreatic beta cells (1).
Chlorpropamide is not widely used in current European guidelines and is not a first‑line sulfonylurea; it is essentially surpassed by shorter‑acting, safer age…